ultiple myeloma (MM) is a type of plasma cell disorder in which a clone of malignant plasma cells forms in the bone marrow, producing an abnormal amount of dysfunctional immunoglobulin. An estimated 13,600 Americans will be diagnosed with MM this year, with approximately 11,200 deaths. The median age at diagnosis is 70 years, with a higher incidence in black males. Previously, MM was a disease with limited treatment choices and poor long-term survival. However, significant progress has been made in understanding its pathophysiology and in developing approaches for treatment and supportive care. Nurses play an important role in achieving optimum treatment through symptom management, education, and coordination of care.
